跳至主要内容
临床试验/ACTRN12622000467730
ACTRN12622000467730招募中未知

Evaluation of the effect of continuous positive airway pressure treatment on cardiopulmonary exercise capacity in Chinese patients with moderate to severe obstructive sleep apnea

Cheng Hei Shun0 个研究点目标入组 60 人开始时间: 2022年3月24日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • a) Chinese patients
  • b) 18 – 70 years old
  • c) Newly diagnosed with moderate to severe OSA confirmed by polysomnography (PSG)

排除标准

  • a) Pre-existing known pulmonary/cardiac diseases
  • b) Left ventricular ejection fraction (LVEF) <50% or significant valvular disease detected in echocardiogram
  • c) Ethnicity other than Chinese
  • d) Invalid informed consent
  • e) Previously or currently on OSA treatment (CPAP/Oral appliance/Surgical treatment)
  • f) Sleep disorder other than OSA (e.g. central sleep apnea)
  • g) Obesity hypoventilation syndrome
  • h) Contraindication to CPAP treatment
  • i) Contraindication to cardiopulmonary exercise test
  • j) Known thyroid/renal/hepatic/neurological disease
  • k) Known musculoskeletal disorder
  • l) Mentally incapable
  • n) Peripheral vascular disease
  • o) Alcohol/substance abuse
  • p) Current medication including sedatives/sympathomimetics
  • q) Acute respiratory/cardiovascular event within six weeks of cardiopulmonary exercise test

研究者

发起方
Cheng Hei Shun

相似试验